Registro:

Referencias:

• New, M.I., White, P.C., Pang, S., Dupont, B., Speiser, P.W., (1989) The Metabolic Basis of Inherited Disease, pp. 1881-1917. , The adrenal hyperplasias New York Press
• Miller, W.L., Genetics, diagnosis and management of 21-hydroxylase deficiency (1994) J Clin Endocrinol Metab, 78, pp. 241-246
• Pang, S., Shook, M.K., Current status of neonatal screening for congenital adrenal hyperplasia (1997) Current Opinion in Pediatrics, 9 (4), pp. 419-423
• Therell, B.L., Newborn screening for congenital adrenal hyperplasia (2001) Endocrinol Metab Clin North Am, 30, pp. 15-30
• Van Der Kamp, H.J., Wit, J.M., Neonatal screening for congenital adrenal hyperplasia (2004) Eur J Endocrinol, 151, pp. U71-U75
• Merke, D.P., Bornstein, S.R., Congenital adrenal hyperplasia (2005) Lancet, 365 (9477), pp. 2125-2136. , DOI 10.1016/S0140-6736(05)66736-0, PII S0140673605667360
• Speiser, P.W., Dupont, B., Rubinstein, P., High frequency of nonclassical steroid 21-hydroxylase deficiency (1985) American Journal of Human Genetics, 37 (4), pp. 650-667
• Donohoue, P.A., Van Dop, C., McLean, R.H., Gene conversion in salt-losing congenital adrenal hyperplasia with absent complement C4B protein (1986) Journal of Clinical Endocrinology and Metabolism, 62 (5), pp. 995-1002
• Higashi, Y., Tanae, A., Inoue, H., Fujii-Kuriyama, Y., Evidence for frequent gene conversion in the steroid 21-hydroxylase P-450 (C21) gene: Implications for steroid 21-hydroxylase deficiency (1988) American Journal of Human Genetics, 42 (1), pp. 17-25
• White, P.C., Speiser, P.W., Congenital adrenal hyperplasia due to 21-hydroxylase deficiency (2000) Endocrine Reviews, 21 (3), pp. 245-291. , DOI 10.1210/er.21.3.245
• Robins, T., Carlsson, J., Sunnerhagen, M., Wedell, A., Persson, B., Molecular model of human CYP21 based on mammalian CYP2C5: Structural features correlate with clinical severity of mutations causing congenital adrenal hyperplasia (2006) Molecular Endocrinology, 20 (11), pp. 2946-2964. , http://mend.endojournals.org/cgi/reprint/20/11/2946, DOI 10.1210/me.2006-0172
• Minutolo, C., Nadra, A., Fernández, C., Taboas, M., Buzzalino, N., Structure-based analysis of five disease causing-mutation in 21-Hydroxylase deficient patients (2011) PLoS ONE, , doi:10.1371/journal.pone.0015899
• Haider, S., Islam, B., D'Atri, V., Sgobba, M., Poojari, C., Structure-phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia (2013) Proc Natl Acad Sci USA, 110, pp. 2605-2610
• Den Dunnen, J.T., Antonarakis, S.E., Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion (2000) Hum Mutat, 15, pp. 7-12
• White, P.C., New, M.I., Dupont, B., Structure of human steroid 21-hydroxylase genes (1986) Proceedings of the National Academy of Sciences of the United States of America, 83 (14), pp. 5111-5115
• Dain, L.B., Buzzalino, N.D., Oneto, A., Belli, S., Stivel, M., Pasqualini, T., Minutolo, C., Alba, L.G., Classical and nonclassical 21-hydroxylase deficiency: A molecular study of Argentine patients (2002) Clinical Endocrinology, 56 (2), pp. 239-245. , DOI 10.1046/j.0300-0664.2001.01419.x
• Pasqualini, T., Alonso, G., Tomasini, R., Galich, A.M., Buzzalino, N., Fernandez, C., Minutolo, C., Dain, L., Congenital adrenal hyperplasia. Clinical characteristics and genotype in newborn, childhood and adolescence (2007) Medicina, 67 (3), pp. 253-261
• Owerbach, D., Ballard, L., Draznin, M.B., Salt-wasting congenital adrenal hyperplasia: Detection and characterization of mutations in the steroid 21-hydroxylase gene, CYP21, using the polymerase chain reaction (1992) J Clin Endocrinol Metab, 74, pp. 553-558
• Wedell, A., Luthman, H., Steroid 21-hydroxylase deficiency: Two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations (1993) Human Molecular Genetics, 2 (5), pp. 499-504
• Desmet, F.O., Hamroun, D., Lalande, M., Collod-Béroud, G., Claustres, M., Splicing Finder: An online bioinformatics tool to predict splicing signals (2009) Nucleic Acids Res, E67. , doi:10.1093/nar/gkp215
• Krone, N., Riepe, F.G., Grotzinger, J., Partsch, C.-J., Sippell, W.G., Functional characterization of two novel point mutations in the CYP21 gene causing simple virilizing forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (2005) Journal of Clinical Endocrinology and Metabolism, 90 (1), pp. 445-454. , DOI 10.1210/jc.2004-0813
• Bleicken, C., Loidi, L., Dhir, V., Parajes, S., Quinteiro, C., Functional characterization of three CYP21A2 sequence variants (p.A265V, p.W302S, p.D322G) employing a yeast co-expression system (2009) Hum Mutat, 30, pp. 443-450
• Tusie-Luna, M.-T., Traktman, P., White, P.C., Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus (1990) Journal of Biological Chemistry, 265 (34), pp. 20916-20922
• Solari, J.J.F., Pozzi, A.G., Ceballos, N.R., Seasonal changes in the activity of cytochrome P450C17 from the testis of Bufo arenarum (2002) Journal of Comparative Physiology B: Biochemical, Systemic, and Environmental Physiology, 172 (8), pp. 685-690. , DOI 10.1007/s00360-002-0296-6
• Bradford, M.M., A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye banding (1976) Anal Biochem, 72, pp. 248-254
• Ghayee, H.K., Rege, J., Watumull, L.M., Nwariaku, F.E., Carrick, K.S., Clinical, Biochemical, and Molecular Characterization of Macronodular Adrenocortical Hyperplasia of the Zona Reticularis: A New Syndrome (2011) J Clin Endocrinol Metab, 96, pp. 243-250
• Muro, A.F., Caputi, M., Pariyarath, R., Pagani, F., Buratti, E., Baralle, F.E., Regulation of fibronectin EDA exon alternative splicing: Possible role of RNA secondary structure for enhancer display (1999) Molecular and Cellular Biology, 19 (4), pp. 2657-2671
• Chu, X., Ding, H., Cui, G., Xu, Y., Wang, D.W., Functional consequences of a novel point mutation in the CYP21A2 gene identified in a Chinese Han patient with nonclassic 21-hydroxylase deficiency (2013) Clin Endocrinol, , doi:10.1111/cen.12309
• Nikoshkov, A., Lajic, S., Vlamis-Gardikas, A., Tranebjaerg, L., Holst, M., Wedell, A., Luthman, H., Naturally occurring mutants of human steroid 21-hydroxylase (P450c21) pinpoint residues important for enzyme activity and stability (1998) Journal of Biological Chemistry, 273 (11), pp. 6163-6165. , DOI 10.1074/jbc.273.11.6163
• Nikoshkov, A., Lajic, S., Holst, M., Wedell, A., Luthman, H., Synergistic effect of partially inactivating mutations in steroid 21- hydroxylase deficiency (1997) Journal of Clinical Endocrinology and Metabolism, 82 (1), pp. 194-199. , DOI 10.1210/jc.82.1.194
• Menassa, R., Tardy, V., Despert, F., Bouvattier-Morel, C., Brossier, J.P., Cartigny, M., Morel, Y., p.H62L, a rare mutation of the CYP21 gene identified in two forms of 21-hydroxylase deficiency (2008) Journal of Clinical Endocrinology and Metabolism, 93 (5), pp. 1901-1908. , http://jcem.endojournals.org/cgi/reprint/93/5/1901, DOI 10.1210/jc.2007-2701
• Soardi, F.C., Barbaro, M., Lau, I.F., Lemos-Marini, S.H.V., Baptista, M.T.M., Guerra Jr., G., Wedell, A., De Mello, M.P., Inhibition of CYP21A2 enzyme activity caused by novel missense mutations identified in brazilian and scandinavian patients (2008) Journal of Clinical Endocrinology and Metabolism, 93 (6), pp. 2416-2420. , http://jcem.endojournals.org/cgi/reprint/93/6/2416, DOI 10.1210/jc.2007-2594
• Tardy, V., Menassa, R., Sulmont, V., Lienhardt-Roussie, A., Lecointre, C., Phenotype-genotype correlations of 13 rare CYP21A2 mutations detected in 46 patients affected with 21-hydroxylase deficiency and in one carrier (2010) J Clin Endocrinol Metab, 95, pp. 1288-1300
• Wilson, R.S., Mercado, A.B., Cheng, K.C., New, M.I., Steroid 21-hydroylase deficiency: Genotype may not predict phenotype (1995) J Clin Endocrinol Metab, 80, pp. 2322-2329
• Jaaskelainen, J., Levo, A., Voutilainen, R., Partanen, J., Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: Good correlation in a well defined population (1997) Journal of Clinical Endocrinology and Metabolism, 82 (10), pp. 3293-3297. , DOI 10.1210/jc.82.10.3293
• Nimkarn, S., Cerame, B.I., Wei, J.-Q., Dumic, M., Zunec, R., Brkljacic, L., Skrabic, V., Wilson, R.C., Congenital adrenal hyperplasia (21-hydroxylase deficiency) without demonstrable genetic mutations (1999) Journal of Clinical Endocrinology and Metabolism, 84 (1), pp. 378-381. , DOI 10.1210/jc.84.1.378
• Krone, N., Braun, A., Roscher, A.A., Knorr, D., Schwarz, H.P., Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany (2000) Journal of Clinical Endocrinology and Metabolism, 85 (3), pp. 1059-1065. , DOI 10.1210/jc.85.3.1059
• Ezquieta, B., Cueva, E., Varela, J., Oliver, A., Fernandez, J., Jariego, C., Non-classical 21-hydroxylase deficiency in children: Association of adrenocorticotropic hormone-stimulated 17-hydroxyprogesterone with the risk of compound heterozygosity with severe mutations (2002) Acta Paediatrica, International Journal of Paediatrics, 91 (8), pp. 892-898. , DOI 10.1080/080352502760148595
• Dolzan, V., Solyom, J., Fekete, G., Kovacs, J., Rakosnikova, V., Votava, F., Lebl, J., Battelino, T., Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia (2005) European Journal of Endocrinology, 153 (1), pp. 99-106. , DOI 10.1530/eje.1.01944
• Gomes, L.G., Huang, N., Agrawal, V., Mendonca, B.B., Bachega, T.A.S.S., Miller, W.L., The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency (2008) Journal of Clinical Endocrinology and Metabolism, 93 (7), pp. 2913-2916. , http://jcem.endojournals.org/cgi/reprint/93/7/2913, DOI 10.1210/jc.2008-0304
• Dolzan, V., Prezelj, J., Vidan-Jeras, B., Breskvar, K., Adrenal 21-hydroxylase gene mutations in Slovenian hyperandrogenic women: Evaluation of corticotrophin stimulation and HLA polymorphisms in screening for carrier status (1999) European Journal of Endocrinology, 141 (2), pp. 132-139. , DOI 10.1530/eje.0.1410132
• Admoni, O., Israel, S., Lavi, I., Gur, M., Tenenbaum-Rakover, Y., Hyperandrogenism in carriers of CYP21 mutations: The role of genotype (2006) Clinical Endocrinology, 64 (6), pp. 645-651. , DOI 10.1111/j.1365-2265.2006.02521.x
• Speiser, P.W., Azziz, R., Baskin, L.S., Ghizzoni, L., Hensle, T.W., Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An Endocrine Society clinical practice guideline (2010) J Clin Endocrinol Metab, 95, pp. 4133-4160
• New, M.I., Abraham, M., Gonzalez, B., Dumic, M., Razzaghy-Azar, M., Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency (2013) Proc Natl Acad Sci USA, 110, pp. 2611-2616
• Lajic, S., Wedell, A., An intron 1 splice mutation and a nonsense mutation (W23X) in CYP21 causing severe congenital adrenal hyperplasia (1996) Human Genetics, 98 (2), pp. 182-184. , DOI 10.1007/s004390050186
• Ordonez-Sanchez, M.L., Ramirez-Jimenez, S., Lopez-Gutierrez, A.U., Riba, L., Gamboa-Cardiel, S., Cerrillo-Hinojosa, M., Altamirano-Bustamante, N., Tusie-Luna, M.T., Molecular genetic analysis of patients carrying steroid 21-hydroxylase deficiency in the Mexican population: Identification of possible new mutations and high prevalence of apparent germ-line mutations (1998) Human Genetics, 102 (2), pp. 170-177. , DOI 10.1007/s004390050672
• Billerbeck, A.E., Mendonca, B.B., Pinto, E.M., Madureira, G., Arnhold, I.J., Three novel mutations in CYP21 gene in Brazilian patients with the classical form of 21-hydroxylase deficiency due to a founder effect (2002) J Clin Endocrinol Metab, 87, pp. 4314-4317
• Lee, H.H., Chao, H.T., Lee, Y.J., Shu, S.G., Chao, M.C., Identification of four novel mutations in the CYP21 gene in congenital adrenal hyperplasia in the Chinese (1998) Hum Genet, 103, pp. 304-310
• Lee, H.H., Chang, S.F., Multiple transcripts of the CYP21 gene are generated by the mutation of the splicing donor site in intron 2 from GT to AT in 21-hydroxylase deficiency (2001) J Endocrinol, 171, pp. 397-402
• Robins, T., Bellanne-Chantelot, C., Barbaro, M., Cabrol, S., Wedell, A., Characterization of novel missense mutations in CYP21 causing congenital adrenal hyperplasia (2007) J Mol Med, 85, pp. 247-255
• Ono, M., Kashimada, K., Miyai, K., Onishi, T., Takagi, M., Honma, S., Mizutani, S., In vitro enzyme assay of CYP21A2 mutation (R483Q) by a novel method using liquid chromatography-electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) (2008) Clinical Pediatric Endocrinology, 17 (2), pp. 49-56. , http://www.jstage.jst.go.jp/article/cpe/17/2/49/_pdf, DOI 10.1297/cpe.17.49
• Stikkelbroeck, N.M.M.L., Hoefsloot, L.H., De Wijs, I.J., Otten, B.J., Hermus, A.R.M.M., Sistermans, E.A., CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in the Netherlands: Six novel mutations and a specific cluster of four mutations (2003) Journal of Clinical Endocrinology and Metabolism, 88 (8), pp. 3852-3859. , DOI 10.1210/jc.2002-021681

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------